Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18,578,488
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1,150,630
-
Shares change
-
+35,224
-
Total reported value, excl. options
-
$1,475,000
-
Value change
-
+$40,949
-
Number of buys
-
4
-
Number of sells
-
2
-
Price
-
$1.28
Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q1 2022
As of 31 Mar 2022 UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,150,630 shares of stock of the company.
Largest 10 holders included Nantahala Capital Management, LLC, Board of Trustees of The Leland Stanford Junior University, Ayrton Capital LLC, TRUIST FINANCIAL CORP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, Frontier Wealth Management LLC, and TANDEM CAPITAL MANAGEMENT CORP /ADV.
This table shows 11 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.